Conjugate polysaccharide vaccine

This page covers all Conjugate polysaccharide vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Neisseria meningitidis serogroups A, C, W, Y polysaccharide capsules.

Targets

Neisseria meningitidis serogroups A, C, W, Y polysaccharide capsules

Phase 3 pipeline (1)

• MenACYW135 polysaccharide vaccine · Sanofi · Immunology / Infectious Disease
  MenACYW135 is a conjugate vaccine that stimulates the immune system to produce antibodies against meningococcal serogroups A, C, W, and Y polysaccharide antigens.

Patent intelligence

• conjugate polysaccharide vaccine patent landscape — aggregated cliff calendar, attackable patents, originator estates